• Home
• Find a Physician
• Medical Services
• Health Library
• Patients & Visitors
• Health Care Professionals
• News

Send Email to a Friend

Fill out the form below to send this link to a friend. An email will be sent on your behalf.

1. 1. Fill in the required fields:

   Your Name: Your Email*: Your Friend's Name: Your Friend's Email*:

2. 2. Personalize your message:

   Message Subject: Personal Message:

3. 3. Send

   Your message and a link to the page will be sent to your friend.
   
   Clicking the 'Send Email' button signifies that you have read and agree to our Privacy Policy.

UT Southwestern Medical Center’s Neuro-oncology Program strives to improve the diagnosis and treatment of cancers of the brain, central nervous system and the peripheral nervous system.

Our professionals are also involved in innovative clinical research actively focused on projects that will create new treatments and also improve existing treatments of childhood and adult brain malignancies. Other conditions and illnesses treated include brain and spinal-cord tumors and disorders or the peripheral nervous system.

A team supporting UT Southwestern’s Neuro-oncology Program finds strong representation from academic and clinical physicians in internal medicine, neurological surgery, neurology, neuro-radiology, pediatrics, radiation oncology, pathology and psychiatry. Members of this team from our various treating services will meet formally once a week to discuss each patient’s condition, diagnosis and treatment.

UT Southwestern offers diagnostic procedures for neurological disorders, on both an inpatient and outpatient basis, as follows:

Magnetic Resonance Imaging (MRI) – The state-of-the-art Mary Nell and Ralph B. Rogers Magnetic Resonance Center provides MR imaging and spectroscopy services for UT Southwestern’s cancer patients.

Positron Emission Tomography (PET) – a scanning technique that enables imaging of metabolic processes occurring in the body and brain. Besides providing a valuable tool for early detection and diagnosis of cancer, PET also provides a way to predict whether tumors will respond to various forms of cancer treatment and can help physicians measure how responsive tumor cells have been to treatment.

Patients may also participate in UT Southwestern’s clinical trials, and thus to be part of exciting discoveries that are changing the way patients are diagnosed and treated as they move toward improved health and quality of life.

For more information, see the Health Library.